Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Improving the Care Process for Patients with Advanced Prostate Cancer Release Date: Partner: The American Urological Association Education and Research, Inc.; Astellas | Quality Improvement | Oncology | USA | |
Developing Educational Initiatives for ALK+ Metastatic Non-small Cell Lung Cancer Tyrosine Kinase Inhibitors Therapy Release Date: | Education | Oncology | Canada | |
Accelerating biomarker testing for optimized metastatic colorectal cancer treatment planning across Canada Release Date: Partner: Colorectal Cancer Canada (CCC) | Quality Improvement, Research | Oncology | Canada | |
Transthyretin Cardiac Amyloidosis Fellowship - United States Release Date: | Fellowship | Rare Disease | USA | |
Exploring the Use of Artificial Intelligence (AI) Applications in ALK+ NSCLC Release Date: | Quality Improvement, Research | Oncology | Italy | |
Advances in Migraine Management Release Date: | Education | Internal Medicine | USA | |
Sickle Cell Disease (SCD) Fellowship Release Date: | Fellowship | Rare Disease | USA | |
2025 Headache Medicine Fellowship - US Release Date: | Fellowship | Internal Medicine | USA | |
Sickle Cell Disease Visiting Professorship Program Release Date: | Education | Rare Disease | USA | |
Optimizing Care for Patients with HR+/HER2- or HER2+ (regardless of hormonal status) metastatic Breast Cancer (mBC) Release Date: | Education | Oncology | Spain | |
Research on Diagnostic and Treatment of Invasive Mold Disease Release Date: | Research | Hospital | China |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Quality Improvement initiatives optimizing AF and VTE management in Canada Release Date: Review Process: | ||||
Improving the Management of Patients with Uncontrolled Acromegaly (International Developed Markets) Release Date: Review Process: | ||||
Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including Dialys Release Date: | Education | Hospital | Albania | |
Integrated Approach to Breast Health Equity Release Date: Review Process: | ||||
Patient Registries In Metastatic Breast Cancer Release Date: Review Process: | ||||
Improving Patient Care in Tobacco Dependency Release Date: Review Process: | ||||
Antimicrobial Stewardship in the Latin America Region Release Date: Review Process: | ||||
Management of Atopic Dermatitis – International Developed Markets Release Date: Review Process: | ||||
Improving Standard of Care for Chronic AD Release Date: Review Process: | ||||
NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care Release Date: Review Process: | ||||
Translating the Atopic Dermatitis (AD) Release Date: Review Process: | ||||
UK Oncology Quality Improvement Grants Release Date: Review Process: |